Recent advances of PET in the diagnosis of brain tumors

Frontiers of Radiation Therapy and Oncology

Volumn 33, Issue , 1999, Pages 9-22

  Langen, Karl Josef ^a   Weckesser, Matthias ^a  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BRAIN TUMOR; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; METABOLISM; PROGNOSIS; REVIEW; SCINTISCANNING; TUMOR RECURRENCE;

ANIMALS; BRAIN NEOPLASMS; HUMANS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032670753     PISSN: 00719676     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000061207     Document Type: Article

References (36)

1. Brock CS, Meikle SR, Price P: Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology? Eur J Nucl Med 1997;24:691-705.
2. 18F]-FDG in oncology: A clinical update. Nucl Med Biol 1996;23:717-735.
3. Smith TA: FDG uptake, tumour characteristics and response to therapy: A review. Nucl Med Commun 1998;19:97-105.
4. Ishiwata K, Kubota K, Murakami M, Kubota R, Sasaki T, Ishii S, Senda M: Re-evaluation of amino acid PET studies: Can the protein synthesis rates in brain and tumor tissues be measured in vivo? J Nucl Med 1993;34:1936-1943.
5. 18F]fluorotyrosine. J Nucl Med 1991; 32:1338-1346.
6. Bergström M, Ericson K, Hagenfeldt L, Mosskin M, von Holst H, Noren G, Eriksson L, Ehrin E, Johnstrom P: PET study of methionine accumulation in glioma and normal brain tissue: Competition with branched chain amino acids. J Comput Assist Tomogr 1987;11:208-213.
7. 11C]methionine. J Comput Assist Tomogr 1983;7:1062-1066.
8. Mosskin M, Ericson K, Hindmarsh T, von Holst H, Collins VP, BergströmM, Eriksson L, Johnstrom P: Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference. Acta Radiol 1989; 30:225-232.
9. Coenen HH, Kling P, Stöcklin G: Cerebral metabolism of L-2-18F]fluorotyrosine, a new PET tracer of protein synthesis. J Nucl Med 1989;30:1367-1372.
10. Ogawa T, Miura S, Murakami M, Iida H, Hatazawa J, Inugami A, Kanno I, Yasui N, Sasajima T, UemuraK: Quantitative evaluation of neutral amino acid transport in cerebral gliomas using positron emission tomography and fluorine-18 fluorophenylalanine. Eur J Nucl Med 1996;23:889-895.
11. 124IMT and first clinical results. J Nucl Med 1990;31:281-286.
12. 11C]-L-methionine uptake in cerebral gliomas: A comparative study using SPECT and PET. J Nucl Med 1997;38:517-522.
13. Kuwert T, Morgenroth C,Woesler B, Matheja P, Palkovic S, Vollet B, Samnick S, Maasjosthusmann U, Lerch H, Gildehaus FJ, Wassmann H, Schober O: Uptake of iodine-123-α-methyltyrosine by gliomas and non-neoplastic brain lesions. Eur J Nucl Med 1996;23:1345-1353.
14. Kuwert T, Woesler B, Morgenroth C, Lerch H, Schafers M, Palkovic S, Matheja P, Brandau W, Wassmann H, Schober O: Diagnosis of recurrent glioma with SPECT and iodine-123-alphamethyltyrosine. J Nucl Med 1998;39:23-27.
15. 11C]methionine uptake in brain abscess: A PET study. J Comput Assist Tomogr 1993;17:660-661.
16. Tjuvajev J, Macapinlac H, Daghighian F, Scott A, Ginos J, Finn R, Kothari P, Desai R, Zhang J, Beattie B, Graham M, Larson St, Blasberg R: Imaging of brain tumor proliferative activity with iodine-131-iododeoxyuridine. J Nucl Med 1994;35:1407-1417.
17. Vander Borght T, Pauwels S, Lambotte L, Labar D, De Maeght S, Stroobandt G, Laterre C: Brain tumor imaging with PET and 2-[carbon-11]thymidine. J Nucl Med 1994;35:974-982.
18. Coleman RE, Hoffman JM, Hanson MW, Sostman HD, Schold SC: Clinical application of PET for the evaluation of brain tumors. J Nucl Med 1991;32:616-622.
19. Goldman S, Levivier M, Pirotte B, Brucher JM, Wikler D, Damhaut P, Stanus E, Brotchi J, Hildebrand J: Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy. Cancer 1996;78:1098-1106.
20. 18F]fluoro-2-deoxy-D-glucose in the low-grade glioma. Neurosurgery 1996;39:470-476.
21. Barker FG Jr, Chang SM, Valk PE, Pounds TR, Prados MD: 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant gliomas. Cancer 1997;79:115-126.
22. 11C]L-methionine uptake in gliomas. Neurosurgery 1989;25:720-728.
23. 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 1998;50:1316-1322.
24. Ogawa T, Shishido F, Kanno I, Inugami A, Fujita H, Murakami M, Shimosegawa E, Ito H, Hatazawa J, Okudera T, Uemura K, Yasui N, Mineura K: Cerebral glioma: Evaluation with methionine PET. Radiology 1993;186:45-53.
25. Goldman S, Levivier M, Pirotte B, Brucher JM,Wikler D, Damhaut P, Dethy S, Brotchi J, Hildebrand J: Regional methionine and glucose uptake in high-grade gliomas: A comparative study on PETguided stereotactic biopsy. J Nucl Med 1997;38:1459-1462.
26. Barker FG, Chang SM, Volk PE, Pounds TR, Prados MD: 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma. Cancer 1997;79:115-126.
27. 18F-fluorodeoxyglucose and L-methyl-11Cmethionine for diagnosis of recurrent brain tumor and radiation injury. Acta Radiol 1991;31:197-202.
28. 11C-L-methionine and PET: A case report. Eur Neurol 1993;33:248-251.
29. Blasberg RG: Prediction of brain tumor therapy response by PET. J Neurooncol 1994;22:281-286.
30. Langen KJ,RoosenN,Kuwert T, HerzogH, Kiwit JC,Rota Kops E, Muzik O, Bock WJ, Feinendegen LE: Early effects of intra-arterial chemotherapy in patients with brain tumours studied with PET: Preliminary results. Nucl Med Common 1989;10:779-790.
31. Würker M, Herholz K, Voges J, Pietrzyk U, Treuer H, Bauer B, Sturm V, Heiss WD: Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy. Eur J Nucl Med 1996;23:583-586.
32. Ogawa T, Kanno I, Hatazawa J, Inugami A, Fujita H, Shimosegawa E, Murakami M, Okudera T, Uemura K, Yasui N: Methionine PET for follow-up of radiation therapy of primary lymphoma of the brain. Radiographics 1994;14:101-110.
33. Herholz K, Reulen JH, von Stockhausen HM, Thiel A, Ilmberger J, Kessler J, Eisner W, Yousry T, Heiss WD: Preoperative activation and intraoperative stimulation of language-related areas in patients with glioma. Neurosurgery 1997;41:1253-1262.
34. Wunderlich G, Knorr U, Herzog H, Kiwit JC, Freund HJ, Seitz RJ: Precentral glioma location determines the displacement of cortical hand representation. Neurosurgery 1998;42:18-26.
35. Nariai T, Senda M, Ishii K, Machara T, Wakabayashi S, Toyama H, Ishiwata K, Hirakawa K: Three-dimensional imaging of cortical structure, function and glioma for tumor resection. J Nucl Med 1997;38;1563-1568.
36. Seitz RJ, Huang Y, Knorr U, Tellmann L, Herzog H, Freund HJ: Large-scale plasticity of the human motor cortex. Neuroreport 1995;6:742-744.